Contact Information: Contact: Dino Luzzi CEO Medivisor, Inc. Tel: 631.549.7100
Medivisor, Inc. Featured in Profile at WallStreetResearch.org
| Source: Medivisor, Inc.
HUNTINGTON STATION, NY--(Marketwire - October 7, 2008) - Medivisor, Inc. (PINKSHEETS : MVSR ),
developer of next-generation focus driven marketing tools, announced today
that it has been featured in a corporate profile posted at
www.wallstreetresearch.org.
WallStreet Research specializes in the microcap and smallcap arena, looking
for emerging growth companies with strong management, unique proprietary
technology, creative marketing, significant market potential, value,
financial strength and outstanding long-term earnings growth.
"It is extremely encouraging that in spite of the current market climate,
Medivisor's recent developments and outlook continue to be recognized by
analysts. Not only has Medivisor, Inc. received a 'Speculative Buy Rating'
at www.BeaconEquity.com, but it has also been profiled on the website
http://www.wallstreetresearch.org," stated Dino Luzzi, CEO of Medivisor,
Inc.
About Medivisor, Inc.:
Medivisor, Inc., is a developer of next-generation focus driven marketing
tools, dedicated to providing technologies that offer innovative and
competitive advantages to the bioscience and pharmaceutical markets. From
pre-product development through product launch and commercialization,
Medivisor offers worldwide experience in delivering effective and
successful integrated marketing and creative communications campaigns for
the benefit of its clients.
Safe Harbor
This press release contains forward-looking statements within the meaning
of the Private Securities Litigation Reform Act of 1995 (the "Act")
Additionally, words such as "seek," "intend," "believe," "plan,"
"estimate," "expect," "anticipate" and other similar expressions are
forward-looking statements within the meaning of the Act. Some or all of
the events or results anticipated by these forward-looking statements may
not occur. Further information on Medivisor risk factors is contained in
its filings with the Securities and Exchange Commission. Medivisor does not
undertake any duty nor does it intend to update the results of these
forward-looking statements.